Nanobiotix S.A. (NASDAQ: NBTX)
$5.38
-0.0950 ( -1.74% ) 2.1K
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
Market Data
Open
$5.38
Previous close
$5.47
Volume
2.1K
Market cap
$262.62M
Day range
$5.30 - $5.55
52 week range
$4.14 - $11.00
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 2 | May 14, 2024 |
20-f | Annual reports | 277 | Apr 24, 2024 |
6-k | Quarterly Reports | 2 | Apr 24, 2024 |
6-k | Quarterly Reports | 2 | Apr 17, 2024 |
6-k | Quarterly Reports | 2 | Apr 10, 2024 |
6-k | Quarterly Reports | 2 | Apr 02, 2024 |
6-k | Quarterly Reports | 2 | Mar 06, 2024 |
6-k | Quarterly Reports | 2 | Feb 13, 2024 |
6-k | Quarterly Reports | 2 | Jan 31, 2024 |
6-k | Quarterly Reports | 2 | Jan 29, 2024 |